The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Squalenoyl Nanomedicines as Potential Therapeutics
Abstract
Nucleoside analogues display significant anticancer or antiviral activity by interfering with DNA synthesis. However, there are some serious restrictions to their use, including their rapid metabolism and the induction of resistance. We have discovered that the linkage of nucleoside analogues to squalene leads to amphiphilic molecules that self-organize in water as nanoassemblies of 100-300 nm, irrespective of the nucleoside analogue used. The squalenoyl gemcitabine exhibited superior anticancer activity in vitro in human cancer cells and gemcitabine-resistant murine leukemia cells, and in vivo in experimental leukemia both after intravenous and oral administration. The squalenoylation of other antiretroviral nucleosides also led to more potent drugs when tested in primary cultures of HIV-infected lymphocytes. Thus, the squalenoylation is an original technology platform for generating more potent anticancer and antiviral nanomedicines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
Abbruzzese, J. L., Grunewald, R., Weeks, E. A., Gravel, D., Adams, T., Nowak, B., Mineishi, S., Tarassoff, P., Satterlee, W., & Raber, M. N. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.3.491 · Cited by 759
Nucleoside analogues: mechanisms of drug resistance and reversal strategies
Galmarini, C., Mackey, Jr., & Dumontet, C. (2001) · Leukemia · doi:10.1038/sj.leu.2402114 · Cited by 511
Synthesis of 2-deoxy-2,2-difluoro-D-ribose and 2-deoxy-2,2'-difluoro-D-ribofuranosyl nucleosides
Hertel, L. W., Kroin, J. S., Misner, J. W., & Tustin, J. M. (1988) · The Journal of Organic Chemistry · doi:10.1021/jo00246a002 · Cited by 366
Preclinical characteristics of gemcitabine
Plunkett, W., Huang, P., & Gandhi, V. (1995) · Anti-Cancer Drugs · doi:10.1097/00001813-199512006-00002 · Cited by 283
Bouffard, D. Y., Laliberté, J., & Momparler, R. L. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90444-2 · Cited by 192
1-β-arabinofuranosylcytosine in therapy of leukemia: Preclinical and clinical overview
Rustum, Y. M., & Raymakers, R. A. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90022-r · Cited by 75
Cited by
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Recent progress in drug delivery
Li, C., Wang, J., Wang, Y., Gao, H., Wei, G., Huang, Y., Yu, H., Gan, Y., Wang, Y., Mei, L., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.003 · Cited by 818
Nanoparticles in drug delivery: Past, present and future
Couvreur, P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.010 · Cited by 696
Self-citationNanotheranostics for personalized medicine
Mura, S., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.006 · Cited by 527
Self-citationPeptide–drug conjugates as effective prodrug strategies for targeted delivery
Wang, Y., Cheetham, A. G., Angacian, G., Su, H., Xie, L., & Cui, H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.015 · Cited by 514
Nanoprecipitation and the “Ouzo effect”: Application to drug delivery devices
Lepeltier, E., Bourgaux, C., & Couvreur, P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.009 · Cited by 440
Self-citationSqualene: A natural triterpene for use in disease management and therapy
Reddy, L. H., & Couvreur, P. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.005 · Cited by 397
Self-citationCheetham, A. G., Chakroun, R. W., Ma, W., & Cui, H. (2017) · Chem. Soc. Rev. · doi:10.1039/c7cs00521k · Cited by 367
Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections
Abed, N., & Couvreur, P. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.02.009 · Cited by 358
Self-citationFong, C., Le, T., & Drummond, C. J. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15148g · Cited by 338
Angelova, A., Angelov, B., Mutafchieva, R., Lesieur, S., & Couvreur, P. (2011) · Accounts of Chemical Research · doi:10.1021/ar100120v · Cited by 337
Self-citationBiological Importance and Applications of Squalene and Squalane
Kim, S.-K., & Karadeniz, F. (2012) · Advances in Food and Nutrition Research · doi:10.1016/b978-0-12-416003-3.00014-7 · Cited by 332
Lipid–Drug Conjugate for Enhancing Drug Delivery
Irby, D., Du, C., & Li, F. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01027 · Cited by 331
Prodrug-based intracellular delivery of anticancer agents
Bildstein, L., Dubernet, C., & Couvreur, P. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.005 · Cited by 310
Self-citationRecent trends in the design of anticancer polymer prodrug nanocarriers
Delplace, V., Couvreur, P., & Nicolas, J. (2014) · Polym. Chem. · doi:10.1039/c3py01384g · Cited by 287
Self-citationPlant Sources, Extraction Methods, and Uses of Squalene
Lozano-Grande, M. A., Gorinstein, S., Espitia-Rangel, E., Dávila-Ortiz, G., & Martínez-Ayala, A. L. (2018) · International Journal of Agronomy · doi:10.1155/2018/1829160 · Cited by 270
Squalene – biochemistry, molecular biology, process biotechnology, and applications
Spanova, M., & Daum, G. (2011) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201100203 · Cited by 268
Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury
Gaudin, A., Yemisci, M., Eroglu, H., Lepetre-Mouelhi, S., Turkoglu, O. F., Dönmez-Demir, B., Caban, S., Sargon, M. F., Garcia-Argote, S., Pieters, G., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.274 · Cited by 261
Self-citationGemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications
Moysan, E., Bastiat, G., & Benoit, J.-P. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300370t · Cited by 225
Sémiramoth, N., Meo, C. D., Zouhiri, F., Saïd-Hassane, F., Valetti, S., Gorges, R., Nicolas, V., Poupaert, J. H., Chollet-Martin, S., Desmaële, D., et al. (2012) · ACS Nano · doi:10.1021/nn204928v · Cited by 133
Self-citationGohil, N., Bhattacharjee, G., Khambhati, K., Braddick, D., & Singh, V. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00050 · Cited by 121
“To design anticancer therapeutics that target the process, pro-drug strategies dealing with quick and efficient transportation of nucleotide analogs have been employed (Couvreur et al., 2006).”
Background
Metadata
- Authors
- Couvreur, P., Stella, B., Reddy, L. H., Hillaireau, H., Dubernet, C., Desmaële, D., Lepêtre-Mouelhi, S., Rocco, F., Dereuddre-Bosquet, N., Clayette, P., Rosilio, V., Marsaud, V., Renoir, J.-M., & Cattel, L.
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-10-07
- Volume
- 6
- Issue
- 11
- Pages
- 2544-2548
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W1984957474
- Cited by
- 329
- References
- 6
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.